
|Articles|October 1, 2000
Supplements and Featured Publications
- Antibody-Targeted Chemotherapy for the Treatment of Relapsed Acute Myeloid Leukemia
- Volume 6
- Issue 18 Suppl
Antibody-Targeted Chemotherapy for the Treatment of Relapsed Acute Myeloid Leukemia
Advertisement
Articles in this issue
about 25 years ago
Continuing Medical Education Quizabout 25 years ago
Overview: Treatment of Acute Myeloid LeukemiaNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Once-Monthly Maridebart Cafraglutide Shows Up to 16% Weight Loss
2
EPCORE FL-1: Adding Epcoritamab to R2 Delivers “New Benchmark” in Second-Line Follicular Lymphoma
3
'Tis the Season: SABCS 2025 to Highlight Latest Advances Across the Breast Cancer Continuum
4
Fixed-Duration Epcoritamab Plus Chemotherapy Yields Response, Remissions in DLBCL
5














































